HK1259279A1 - 用於細胞封裝和細胞治療的改性藻朊酸鹽 - Google Patents
用於細胞封裝和細胞治療的改性藻朊酸鹽Info
- Publication number
- HK1259279A1 HK1259279A1 HK19101640.1A HK19101640A HK1259279A1 HK 1259279 A1 HK1259279 A1 HK 1259279A1 HK 19101640 A HK19101640 A HK 19101640A HK 1259279 A1 HK1259279 A1 HK 1259279A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cell
- modified alginates
- encapsulation
- therapy
- cell therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161492705P | 2011-06-02 | 2011-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1259279A1 true HK1259279A1 (zh) | 2019-11-29 |
Family
ID=46321466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK19101640.1A HK1259279A1 (zh) | 2011-06-02 | 2019-01-30 | 用於細胞封裝和細胞治療的改性藻朊酸鹽 |
Country Status (7)
Country | Link |
---|---|
US (6) | US9422373B2 (zh) |
EP (3) | EP2714747B1 (zh) |
CA (1) | CA2837558C (zh) |
DK (1) | DK3354665T5 (zh) |
ES (1) | ES2912545T3 (zh) |
HK (1) | HK1259279A1 (zh) |
WO (1) | WO2012167223A1 (zh) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2956075C (en) * | 2014-08-01 | 2020-03-10 | Massachusetts Institute Of Technology | Modified alginates for anti-fibrotic materials and applications |
US10596123B2 (en) | 2015-03-11 | 2020-03-24 | Mayo Foundation For Medical Education And Research | Exosome delivery technology |
DK3368085T3 (da) | 2015-11-01 | 2024-04-02 | Massachusetts Inst Technology | Modificerede alginater til anti-fibrotiske materialer og anvendelser |
JP6840751B2 (ja) * | 2015-11-01 | 2021-03-10 | マサチューセッツ インスティテュート オブ テクノロジー | 改善された性質を有する材料 |
US10697972B2 (en) | 2016-01-12 | 2020-06-30 | Bioatla, Llc | Diagnostics using conditionally active antibodies |
EP3403098B1 (en) | 2016-01-12 | 2021-09-22 | BioAtla, Inc. | Diagnostics using conditionally active antibodies |
US9999640B2 (en) | 2016-02-02 | 2018-06-19 | University Of Dammam | Microencapsulated probiotic bacteria |
US10046985B2 (en) | 2016-02-11 | 2018-08-14 | King Fahd University Of Petroleum And Minerals | Method for removing cationic dyes from an aqueous solution using an adsorbent |
EP3433282B1 (en) | 2016-03-24 | 2022-07-13 | Takeda Pharmaceutical Company Limited | Alginate hydrogel compositions |
EP3468633A1 (en) | 2016-06-13 | 2019-04-17 | Massachusetts Institute Of Technology | Surface-coated continuous glucose monitors |
EP3295933A1 (en) | 2016-09-14 | 2018-03-21 | Ecole Polytechnique Federale De Lausanne (Epfl) | Hydrogels based on functionalized polysaccharides |
WO2018050764A1 (en) | 2016-09-14 | 2018-03-22 | Ecole Polytechnique Federale De Lausanne (Epfl) | Hydrogels based on functionalized polysaccharides |
RU2019126801A (ru) * | 2017-01-27 | 2021-03-02 | Корнелл Юниверсити | Полимеры и гидрогели, модифицированные цвиттер-ионом |
US20180353650A1 (en) | 2017-06-13 | 2018-12-13 | Massachusetts Institute Of Technology | Biocompatible microfabricated macrodevices for transplanting cells |
JP2020534837A (ja) | 2017-09-27 | 2020-12-03 | シギロン セラピューティクス, インコーポレイテッドSigilon Therapeutics, Inc. | 活性細胞を含む方法、組成物、及び移植可能な要素 |
WO2019090309A1 (en) | 2017-11-06 | 2019-05-09 | Massachusetts Institute Of Technology | Anti-inflammatory coatings to improve biocompatibility of neurological implants |
AU2019226587A1 (en) | 2018-03-02 | 2020-09-03 | Sigilon Therapeutics, Inc. | Afibrotic compounds, devices, and uses thereof |
US20210002433A1 (en) | 2018-03-02 | 2021-01-07 | Sigilon Therapeutics, Inc. | Biocompatible hydrogel capsules and process for preparing same |
EP3765590A4 (en) * | 2018-03-16 | 2021-12-22 | NUtech Ventures | CELL GROWTH SYSTEM |
IL312315A (en) | 2018-04-04 | 2024-06-01 | Sigilon Therapeutics Inc | Implantable particles and related methods |
US20210145889A1 (en) | 2018-04-04 | 2021-05-20 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising stem cells |
WO2019240219A1 (ja) | 2018-06-14 | 2019-12-19 | 持田製薬株式会社 | 新規な架橋アルギン酸 |
US20210353781A1 (en) * | 2018-09-21 | 2021-11-18 | Massachusetts Institute Of Technology | Surface-modified cells, methods of making and using |
UY38389A (es) | 2018-09-27 | 2020-04-30 | Sigilon Therapeutics Inc | Dispositivos implantables para terapia celular y métodos relacionados |
JP2022520097A (ja) | 2019-02-15 | 2022-03-28 | ウィリアム マーシュ ライス ユニバーシティ | 移植診断および治療のための血管形成デバイスおよび方法 |
JP7236533B2 (ja) | 2019-04-09 | 2023-03-09 | 富士フイルム株式会社 | マイクロカプセルの製造方法およびコート液 |
EP4019025A4 (en) | 2019-08-23 | 2022-11-30 | FUJIFILM Corporation | COMPOSITION COMPRISING A MICROCAPSULE AND A CELLULAR STRUCTURE |
CN116096401A (zh) * | 2020-04-02 | 2023-05-09 | 康奈尔大学 | 应用纳米纤维的封装装置及其用途 |
EP3940072A1 (en) * | 2020-07-13 | 2022-01-19 | Biomillenia SAS | Alginate beads and production thereof |
US20220089537A1 (en) | 2020-09-18 | 2022-03-24 | Massachusetts Institute Of Technology | High-throughput method to rapidly add chemical moieties to a small molecule library |
WO2023230524A1 (en) | 2022-05-25 | 2023-11-30 | Flagship Pioneering Innovations Vi, Llc | Compositions of secretory and/or catalytic cells and methods using the same |
WO2023235884A1 (en) | 2022-06-03 | 2023-12-07 | Flagship Pioneering Innovations Vi, Llc | Compositions and methods |
WO2024006528A1 (en) | 2022-07-01 | 2024-01-04 | Sigilon Therapeutics, Inc. | Covalently photocrosslinked polysaccharides and methods of use thereof |
WO2024081309A1 (en) | 2022-10-11 | 2024-04-18 | Sigilon Therapeutics, Inc. | Engineered cells and implantable elements for treatment of disease |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB676618A (en) * | 1947-09-12 | 1952-07-30 | Kelco Co | Alkylene glycol esters of alginic acid |
GB768309A (en) * | 1954-03-27 | 1957-02-13 | Henkel & Cie Gmbh | Process for the production of amides of alginic acid |
US2860130A (en) * | 1954-11-01 | 1958-11-11 | Kelco Co | Methyl alginate |
US2881161A (en) * | 1955-03-25 | 1959-04-07 | Henkel & Cie Gmbh | Amides of alginic acid |
US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
NO845059L (no) | 1984-12-17 | 1986-06-18 | Sintef Inst For Marin Biokjemi | Fremgangsmaate for fremstilling av alginater med endrede fysikalske egenskaper samt anvendelse av disse alginater. |
IT1203814B (it) * | 1986-06-30 | 1989-02-23 | Fidia Farmaceutici | Esteri dell'acido alginico |
JP2643669B2 (ja) | 1990-12-28 | 1997-08-20 | 共成製薬株式会社 | アルギン含有食品 |
US5876452A (en) | 1992-02-14 | 1999-03-02 | Board Of Regents, University Of Texas System | Biodegradable implant |
GB2270920B (en) | 1992-09-25 | 1997-04-02 | Univ Keele | Alginate-bioactive agent conjugates |
FR2699545B1 (fr) | 1992-12-18 | 1995-01-27 | Oreal | Agent gélifiant résultant de l'association d'un chitosane et d'un alginate d'alkyle ou d'hydroxyalkyle et son utilisation dans la préparation de compositions cosmétiques et pharmaceutiques. |
US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
EP2025353A2 (en) | 1993-04-30 | 2009-02-18 | Massachusetts Institute of Technology | Injectable polysaccharide-cell compositions |
US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
US6171232B1 (en) | 1997-06-26 | 2001-01-09 | Cordis Corporation | Method for targeting in vivo nitric oxide release |
US6440940B1 (en) | 1997-12-18 | 2002-08-27 | Peter J. Doyle | Bioresorbable alginate derivatives |
US6159531A (en) | 1999-08-30 | 2000-12-12 | Cardiovasc, Inc. | Coating having biological activity and medical implant having surface carrying the same and method |
US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
US6977138B2 (en) | 2001-07-24 | 2005-12-20 | Massachusetts Institute Of Technology | Reactive polymer coatings |
PT1509256E (pt) | 2002-05-24 | 2009-10-15 | Angiotech Int Ag | Composições e métodos de revestimento de implantes médicos |
US7008476B2 (en) | 2003-06-11 | 2006-03-07 | Az Electronic Materials Usa Corp. | Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof |
US7329531B2 (en) | 2003-12-12 | 2008-02-12 | Scimed Life Systems, Inc. | Blood-tight implantable textile material and method of making |
WO2005063147A1 (en) | 2003-12-23 | 2005-07-14 | Fmc Biopolymer As | Use of alginate matrices to control cell growth |
ITMI20041373A1 (it) * | 2004-07-09 | 2004-10-09 | Lima Lto S P A | N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido |
JP2008519595A (ja) | 2004-11-12 | 2008-06-12 | エフエムシー バイオポリマー エイエス | 変性アルギネートおよびその製造方法および用途 |
ES2377479T3 (es) * | 2005-09-27 | 2012-03-28 | Universite Joseph Fourier - Grenoble 1 | Hidrogel funcionalizado con una porción polimerizable y sus utilizaciones como biosensores o biorreactores. |
DE102005049833A1 (de) | 2005-10-14 | 2007-04-19 | Beiersdorf Ag | Hydrophob modifizierte Alginate |
ES2804472T3 (es) | 2005-12-13 | 2021-02-08 | Harvard College | Estructuras para trasplante celular |
US8211361B2 (en) | 2007-03-26 | 2012-07-03 | Board Of Regents, The University Of Texas System | N-halamine-based rechargeable biofilm-controlling tubular devices, method of making and using |
US7515808B2 (en) | 2007-06-01 | 2009-04-07 | Alcatel-Lucent Usa Inc. | Thermally stabilized waveguides |
AU2008296975B2 (en) | 2007-08-28 | 2014-07-24 | Fmc Corporation | Delayed self-gelling alginate systems and uses thereof |
US7998524B2 (en) | 2007-12-10 | 2011-08-16 | Abbott Cardiovascular Systems Inc. | Methods to improve adhesion of polymer coatings over stents |
EP2127689A1 (en) | 2008-05-27 | 2009-12-02 | RevisiOs B.V. i.o. | Novel homogenous osteoinductive nanocomposites |
CN101565469B (zh) * | 2008-10-28 | 2011-05-11 | 中国海洋大学 | 酰胺接枝的海藻酸钠纳米材料及其制备方法与应用 |
US8802738B2 (en) | 2008-12-12 | 2014-08-12 | University Of Massachusetts | Polyesters with grafted zwitterions |
WO2010090767A2 (en) | 2009-02-09 | 2010-08-12 | St. Jude Medical, Inc. | Enhancing biocompatibility of a medical device |
US9555154B2 (en) | 2009-02-21 | 2017-01-31 | Covidien Lp | Medical devices having activated surfaces |
EP2488225A1 (en) | 2009-10-16 | 2012-08-22 | DSM IP Assets B.V. | Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide |
WO2012009377A2 (en) | 2010-07-12 | 2012-01-19 | University Of Southern California | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
US20120083767A1 (en) | 2010-10-01 | 2012-04-05 | The Johns Hopkins University | Implantable bioreactor for delivery of paracrine factors |
JP5963130B2 (ja) | 2012-02-16 | 2016-08-03 | 学校法人同志社 | 生体組織補強材料キット及び生体組織補強材料 |
-
2012
- 2012-06-04 CA CA2837558A patent/CA2837558C/en active Active
- 2012-06-04 DK DK18162427.1T patent/DK3354665T5/da active
- 2012-06-04 WO PCT/US2012/040665 patent/WO2012167223A1/en unknown
- 2012-06-04 EP EP12728887.6A patent/EP2714747B1/en active Active
- 2012-06-04 US US13/487,524 patent/US9422373B2/en active Active
- 2012-06-04 EP EP22165043.5A patent/EP4083074A1/en active Pending
- 2012-06-04 EP EP18162427.1A patent/EP3354665B9/en active Active
- 2012-06-04 ES ES18162427T patent/ES2912545T3/es active Active
-
2016
- 2016-07-12 US US15/208,192 patent/US10285949B2/en active Active
-
2017
- 2017-05-05 US US15/588,481 patent/US10292936B2/en active Active
-
2019
- 2019-01-30 HK HK19101640.1A patent/HK1259279A1/zh unknown
- 2019-05-10 US US16/408,899 patent/US10842753B2/en active Active
-
2020
- 2020-10-26 US US17/080,355 patent/US11337930B2/en active Active
-
2022
- 2022-05-20 US US17/749,795 patent/US20230130084A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20120308650A1 (en) | 2012-12-06 |
US20160324793A1 (en) | 2016-11-10 |
US10292936B2 (en) | 2019-05-21 |
ES2912545T3 (es) | 2022-05-26 |
EP2714747B1 (en) | 2020-08-05 |
US20210186886A1 (en) | 2021-06-24 |
DK3354665T5 (da) | 2022-09-19 |
US20230130084A1 (en) | 2023-04-27 |
US10285949B2 (en) | 2019-05-14 |
CA2837558C (en) | 2018-11-20 |
EP4083074A1 (en) | 2022-11-02 |
US10842753B2 (en) | 2020-11-24 |
EP3354665B1 (en) | 2022-03-30 |
US9422373B2 (en) | 2016-08-23 |
EP2714747A1 (en) | 2014-04-09 |
WO2012167223A1 (en) | 2012-12-06 |
EP3354665A1 (en) | 2018-08-01 |
US11337930B2 (en) | 2022-05-24 |
CA2837558A1 (en) | 2012-12-06 |
US20170239190A1 (en) | 2017-08-24 |
US20190262272A1 (en) | 2019-08-29 |
EP3354665B9 (en) | 2022-08-03 |
DK3354665T3 (da) | 2022-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1259279A1 (zh) | 用於細胞封裝和細胞治療的改性藻朊酸鹽 | |
HK1214626A1 (zh) | 重編程細胞 | |
HK1213016A1 (zh) | 細胞調節化合物及其用途 | |
AP2013007178A0 (en) | BCMA-based stratification and therapy for multiplemyeloma patients | |
EP2680862A4 (en) | ENCAPSULATED CELLS FOR SUBSTITUTIVE HORMONOTHERAPY | |
IL228184B (en) | Low fucose cell lines and uses thereof | |
EP2739144A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
EP2709200A4 (en) | LEAD ACCUMULATOR | |
EP2658556A4 (en) | METHODS OF CRYOPRESERVATION AND ENCAPSULATION OF CELLS | |
EP2782184A4 (en) | BATTERY | |
EP2717377A4 (en) | DRUMS | |
GB201017421D0 (en) | Cell | |
EP2677593A4 (en) | CELL HOUSING AND STRUCTURE FOR FIXING THE CELL HOUSING | |
EP2722386A4 (en) | CELLS MOLDED AND COMPOSITION BASED THEREON | |
EP2725637A4 (en) | BATTERY | |
EP2690698A4 (en) | BATTERY | |
EP2750508A4 (en) | COMPOUNDS AND THERAPEUTIC METHODS | |
EP2755264A4 (en) | BATTERY | |
GB201005394D0 (en) | Therapy | |
GB201016864D0 (en) | Therapeutic methods | |
GB2484028B (en) | Power-scalable betavoltaic battery | |
EP2593113A4 (en) | CELL THERAPY | |
ZA201207816B (en) | Battery capsule | |
GB201102228D0 (en) | Inventions and therapy | |
GB201102234D0 (en) | Inventions and therapy |